Eledon Pharmaceuticals
ELDN
ELDN
34 hedge funds and large institutions have $74.5M invested in Eledon Pharmaceuticals in 2021 Q2 according to their latest regulatory filings, with 6 funds opening new positions, 13 increasing their positions, 7 reducing their positions, and 6 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more ownership
Funds ownership: →
more funds holding
Funds holding: →
more first-time investments, than exits
New positions opened: | Existing positions closed:
16% less capital invested
Capital invested by funds: $89M → $74.5M (-$14.4M)
Holders
34
Holding in Top 10
–
Calls
–
Puts
–
Top Buyers
| 1 | +$8.83M | |
| 2 | +$6.64M | |
| 3 | +$791K | |
| 4 |
Point72 Asset Management
Stamford,
Connecticut
|
+$504K |
| 5 |
Two Sigma Advisers
New York
|
+$476K |
Top Sellers
| 1 | -$11.9M | |
| 2 | -$311K | |
| 3 | -$268K | |
| 4 |
WP
Woodline Partners
San Francisco,
California
|
-$266K |
| 5 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
-$238K |